-
<![CDATA[Chemotherapy Combination Boosts Overall Survival in Patients With EGFR-Mutant Non-Small Cell Lung Cancer]]>
24 Oct 2025 22:54 GMT
… non-small cell lung cancer (NSCLC) compared to … co-led by researchers from Dana-Farber Cancer Institute and Gustave Roussy … for Thoracic Oncology at Dana-Farber.
Jänne presented data showing … non-small cell lung cancer, including combination therapies and …
-
SIAA’s Fall Business Meeting Raises Awareness and Funds for Dana-Farber Cancer Institute
24 Oct 2025 10:07 GMT
… as raise funds for the Dana-Farber Cancer Institute (DFCI). This year, the … event for SIAA and the Dana-Farber Cancer Institute, and the funds raised …
-
Remix Therapeutics Announces Positive Preliminary Data from Phase 1 Study of REM-422 in Patients with Adenoid Cystic Carcinoma at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
24 Oct 2025 14:00 GMT
… . Hanna, MD, Director, Center for Cancer Therapeutic Innovation (Early Drug Development … for Head & Neck Oncology, Dana-Farber Cancer Institute and Associate Professor of … targeting MYB, a previously intractable cancer driver. The results support REM …
-
Health Rounds: Combo drugs improve on chemo alone for certain breast cancer patients
24 Oct 2025 13:10 GMT
… .
Trodelvy combines the cancer-cell-targeting antibody sacituzumab … Sara Tolaney of the Dana-Farber Cancer Institute presented results of … from Memorial Sloan-Kettering Cancer Center in New York … advanced triple-negative breast cancer for whom immunotherapy was …
-
Letter: Second opinions save lives in cancer care
24 Oct 2025 11:47 GMT
… use cutting-edge breast cancer screening technologies, as Dr … oncology team at Phelps Cancer Center should always be … triple-negative cancers at Dana-Farber Cancer Institute opened the door … -edge immunotherapy treatment. In cancer care, second opinions save …
-
Sacituzumab govitecan improves outcomes for breast cancer subset
23 Oct 2025 20:23 GMT
… metastatic triple-negative breast cancer subset compared with chemotherapy. … negative metastatic triple-negative breast cancer compared with chemotherapy, according … -Castro, MD, breast cancer specialist at Dana-Farber Cancer Institute and assistant professor …
-
<![CDATA[Dr Tarantino on De-Escalated THP With/Without Carboplatin in HER2+ Breast Cancer]]>
23 Oct 2025 18:04 GMT
… the Department of Medicine at Dana-Farber Cancer Institute and Harvard Medical School … with HER2-positive early breast cancer.
neoCARHP compared neoadjuvant taxane therapy … stage II HER2-positive breast cancer, Tarantino explained. However, this approach …
-
No doctor would take her seriously. Now N.J. mom is battling ‘horror movie’ cancer syndrome.
23 Oct 2025 11:00 GMT
… weeks after her breast cancer diagnosis, her doctor called … developing multiple forms of cancer, often beginning in childhood … of cancer genetics and prevention at the Dana-Farber Cancer Institute … diagnosed with advanced lung cancer. She underwent surgery the …
-
What are recent trends in opioid prescribing for patients with cancer?
23 Oct 2025 01:27 GMT
… opioid prescriptions for patients with cancer. Among those patients with metastatic … opioid prescribing for patients with cancer, investigators analyzed data on adults … of the study, now of Dana-Farber Cancer Institute. “Important questions remain regarding …
-
Artist, cancer survivor brings the art of healing to pop-up series
22 Oct 2025 23:14 GMT
… both leukemia and breast cancer, channeling her creative passion … patient care at the Dana-Farber Cancer Institute in Boston and … local women undergoing breast cancer treatment.
“Swing for … directly to female breast cancer patients through MUSC,” O …